Aprecap 150mg Injection (Aprepitant)

Aprecap 150mg Injection

Aprecap 150Mg Injection is an antiemetic. It is used after chemotherapy or after surgery to prevent vomiting and feelings of nausea. It functions by blocking the substances in the brain that cause nausea and vomiting. It can be used in combination with other medications.

On using this medication you may experience side effects such as headache, constipation, chest pain, dizziness, fatigue, heartburn, reduced appetite, diarrhea, irregular heartbeat, mental/mood disorders, breathlessness, hives, sore throat, skin rash, swelling of facial features, fever, trouble breathing or swallowing. If reactions persist or become worse over time seek medical help as soon as possible.

Avoid using this medication if you are allergic to any ingredient contained within Aprecap 150Mg Injection. Before using this medication tell your doctor if: you have nausea or vomiting, you are allergic to any food or medicine or substance, you are taking any prescription or non-prescription drugs, you are pregnant or are planning to become pregnant or are nursing a baby.

The usual adult dose for treating nausea or vomiting post cancer treatment medication is 125 mg orally an hour after chemo on the first day and 80 mg orally for the next two days in the morning. Ideally dosage should be prescribed by the doctor.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Internal Medicine Specialist before using this medicine.

Use

Vomiting

Dosage

Aprecap 125 mg
Aprecap 125/80 Capsule
Aprecap 150mg Injection

Side Effects

Headache

Dyspepsia

Fatigue

Increased Liver Enzymes

Decreased Appetite

Constipation

Dosage

Are there any missed dose instructions?

If you miss a dose of Aprepitant, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Work

Aprecap 150Mg Injection treats nausea and vomiting caused by chemotherapy. It prevents vomiting by blocking cytotoxic chemotherapeutic agents. It does that by requisitioning brain NK1 receptors. It enhances he antiemetic activity of 5-HT3-receptor antagonist ondansetron and the corticosteroid ethason.